Resumen
Aptamers for blocking metastasis of solid tumors. The present invention relates to aptamers capable of inhibiting SNAI2 expression for use as a medicament and, specifically, for use in blocking metastasis of solid tumors, particularly breast tumors, especially tumors of the group consisting of: adenocarcinoma, invasive ductal carcinoma, or metastatic carcinoma. The invention also relates to pharmaceutical compositions that include at least one of the aptamers described in the invention, for use in preventing metastasis of solid tumors and, especially, breast tumors, including: adenocarcinoma, invasive ductal carcinoma, or metastatic carcinoma. (Machine-translation by Google Translate, not legally binding)